Le taux de couverture vaccinale contre le papillomavirus humain (HPV) reste faible en France autour de 20%. Ce travail porte sur l’attitude adoptée par la population française afin de comprendre les motivations et les freins à la vaccination HPV.Une série d’études, qualitatives et quantitatives, a été réalisée en 2014-2016 sur deux populations, la première de jeunes filles de 15 à 25 ans et la deuxième de mères ayant des filles âgées de 11 à 16 ans. Notre approche méthodologique est essentiellement basée sur le modèle combiné issu de la théorie du comportement planifié (Theory of Planned Behavior, TPB, Ajzen, 1991) et du modèle des croyances relatives à la santé (Health Beliefs Model, HBM, Rosenstock, 1974). Parmi les modérateurs de la déci...
INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of...
International audienceOBJECTIVE:General practitioners (GPs) play a crucial role in human papillomavi...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...
The immunization coverage against HPV remains around 20%. The attitude of French girls was studied t...
The purpose of the present thesis was to examine psychosocial and behavioural factors associated wit...
La majorité des cancers liés aux papillomavirus humains (HPV) peut être évitée grâce à la vaccinatio...
International audienceIntroductionThis study aimed to develop and undertake a preliminary validation...
International audienceBackground: The contemporary crisis of trust in vaccines has severely impaired...
Background: In Switzerland, HPV vaccination has been recommended since 2007 for all adolescent girl...
Context: HPV infections are a part of the most frequent sexually transmitted infections in the world...
International audienceBackground The human papillomavirus (HPV) vaccine reduces the burden of cervic...
Objectives: To systematically review, appraise and evaluate available evidence regarding discrete-ch...
OBJECTIVE: To examine which factors determined the participation in HPV vaccination programme in 200...
INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of...
International audienceOBJECTIVE:General practitioners (GPs) play a crucial role in human papillomavi...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...
The immunization coverage against HPV remains around 20%. The attitude of French girls was studied t...
The purpose of the present thesis was to examine psychosocial and behavioural factors associated wit...
La majorité des cancers liés aux papillomavirus humains (HPV) peut être évitée grâce à la vaccinatio...
International audienceIntroductionThis study aimed to develop and undertake a preliminary validation...
International audienceBackground: The contemporary crisis of trust in vaccines has severely impaired...
Background: In Switzerland, HPV vaccination has been recommended since 2007 for all adolescent girl...
Context: HPV infections are a part of the most frequent sexually transmitted infections in the world...
International audienceBackground The human papillomavirus (HPV) vaccine reduces the burden of cervic...
Objectives: To systematically review, appraise and evaluate available evidence regarding discrete-ch...
OBJECTIVE: To examine which factors determined the participation in HPV vaccination programme in 200...
INTRODUCTION: The uptake of human papillomavirus (HPV) vaccination in France remains low. The aim of...
International audienceOBJECTIVE:General practitioners (GPs) play a crucial role in human papillomavi...
Introduction: The vaccination rate in France against Human Papillomavirus (HPV) is only 17%. The mai...